首页> 外文期刊>International immunopharmacology >Imbalanced expression of human Tim-1 and Tim-3 in peripheral blood mononuclear cells from immune thrombocytopenia patients
【24h】

Imbalanced expression of human Tim-1 and Tim-3 in peripheral blood mononuclear cells from immune thrombocytopenia patients

机译:从免疫血小板减少症患者的外周血单核细胞中,人TIM-1和TIM-3的表达

获取原文
获取原文并翻译 | 示例
           

摘要

Background The T-cell immunoglobulin and mucin domain-(Tim)-1 molecule and Tim-3 are mainly expressed on activated T helper (Th) 2 and Th1 cells, respectively, and have been implicated in the pathogenesis of some autoimmune diseases. Immune thrombocytopenia (ITP) is a common autoimmune disorder, and the complex dysregulation of cellular immunity has been observed; however, the relationship between Tims and excessive immune responses in ITP remains unclear. Methods Using real-time quantitative polymerase chain reaction (RT-PCR), the mRNA expression levels of Tim-1, Tim-3, T-box transcription factor (T-bet) and GATA binding protein 3 (GATA-3) were measured in the peripheral blood mononuclear cells (PBMCs) of 45 newly diagnosed patients with active ITP, 34 ITP patients in remission and 31 healthy volunteers. Results Tim-3 mRNA expression in PBMCs in newly diagnosed patients was significantly decreased. At the same time, Tim-1 mRNA was not significantly declined, which resulted in a decreased ratio of Tim-3 to Tim-1 in ITP patients with active disease. During the remission stages, the levels of these transcription factors were comparable with those observed in healthy controls. Conclusions The reduced levels of Tim-3/Tim-1 in PBMCs during active stages of the disease suggest a possible role in the pathogenesis and course of ITP. Regulating the balance of Tim-1 and Tim-3 in ITP patients could also be a therapeutic approach against ITP.
机译:背景技术T细胞免疫球蛋白和粘蛋白结构域 - (TIM)-1分子和TIM-3分别在活化的T辅助杆(TH)2和Th1细胞上,并涉及一些自身免疫疾病的发病机制。免疫血小板减少症(ITP)是一种常见的自身免疫病症,观察到细胞免疫的复杂性失衡;然而,ITP中TIMS和过量免疫应答之间的关系仍不清楚。使用实时定量聚合酶链反应(RT-PCR)的方法,测量TIM-1,TIM-3,T盒转录因子(T-BET)和GATA结合蛋白3(GATA-3)的mRNA表达水平在外周血单核细胞(PBMC)为45例新诊断的活性ITP患者,34名ITP患者缓解和31名健康志愿者。结果新诊断患者PBMC中的TIM-3 mRNA表达显着降低。同时,Tim-1 mRNA没有显着下降,这导致TIM-3与ITP患者有活跃疾病的ITP患者的比例降低。在缓解阶段期间,这些转录因子的水平与在健康对照中观察到的那些相当。结论在疾病的活性阶段期间PBMCS中的TIM-3 / TIM-1水平降低表明,在发病机制和ITP过程中可能作用。调节ITP患者的TIM-1和TIM-3的平衡也可能是针对ITP的治疗方法。

著录项

  • 来源
    《International immunopharmacology》 |2014年第1期|共4页
  • 作者单位

    Department of Hematology Shandong Provincial Hospital Affiliated to Shandong University 324 Jing;

    Department of Hematology Shandong Provincial Hospital Affiliated to Shandong University 324 Jing;

    Department of Hematology Linzi District People's Hospital Zibo 255100 China;

    Department of Hematology Shandong Provincial Hospital Affiliated to Shandong University 324 Jing;

    Department of Hematology Shandong Provincial Hospital Affiliated to Shandong University 324 Jing;

    Department of Hematology Shandong Provincial Hospital Affiliated to Shandong University 324 Jing;

    Department of Hematology Shandong Provincial Hospital Affiliated to Shandong University 324 Jing;

    Department of Hematology Shandong Provincial Hospital Affiliated to Shandong University 324 Jing;

    Department of Hematology Shandong Provincial Hospital Affiliated to Shandong University 324 Jing;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    Immune thrombocytopenia; RT-PCR; T-cell immunoglobulin and mucin domain-3; Tim-1;

    机译:免疫血小板减少;RT-PCR;T细胞免疫球蛋白和粘蛋白结构域-3;TIM-1;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号